Loading clinical trials...
Loading clinical trials...
Phase II Evaluation Of SGN-00101 (HSP-E7) Fusion Protein In Women With Cervical Intraepithelial Neoplasia 3, CIN 3
Conditions
Interventions
HspE7
therapeutic conventional surgery
+1 more
Locations
1
United States
Gynecologic Oncology Group
Philadelphia, Pennsylvania, United States
Start Date
June 1, 2004
Primary Completion Date
January 1, 2007
Last Updated
January 24, 2013
NCT06349642
NCT05639972
NCT07225530
NCT07209917
NCT05581004
NCT05372484
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions